2025年
原著
- Sasahara Y, Gon Y, Hida E. Association between Acute Care Accessibility and in-Hospital Mortality among Patients with Acute Ischemic Stroke. JMA Journal. Apr 2025. 8(2):417-429.
- Dohi T, Ishihara T, Kida H, Nakamura D, Kikuchi A, Kawai T, Mori N, Okamoto N, Ueda Y, Shutta R, Ichikawa M, Mano T, Watanabe T, Higuchi Y, Nishino M, Hida E, Sato T, Hikoso S, Nakatani D, Sotomi Y, Sakata Y. Comparison of drug-coated versus conventional balloons for the side branch of the bifurcation lesion – multicenter randomized controlled study – (OCVC-BIF): Design and rationale. Cardiovascular revascularization medicine : including molecular interventions. Mar 2025.
- Toyoda K, Yoshimura S, Nakai M, Wada S, Miwa K, Koge J, Yoshida T, Kamiyama K, Mizoue T, Hatano T, Yoshida Y, Sasahara Y, Ishigami A, Iwanaga Y, Miyamoto Y, Minematsu K, Kobayashi S, Koga M, Japan Stroke Data Bank Investigators. Severity, Outcomes, and their Secular Changes in 33,870 Ischemic Stroke Patients with Atrial Fibrillation in a Hospital-Based Registry: Japan Stroke Data Bank. Journal of Atherosclerosis and Thrombosis. Mar 2025. 32(3):308-320.
- Kaji H, Yokooji T, Taogoshi T, Izumitani S, Hida E, Matsuo H. Assessment of Risk of Acidosis in Patients with Mild-to-Moderate Chronic Kidney Disease Treated with Intravenous Branched-Chain Amino Acid-Enriched Solution: A Propensity Score Matching Analysis. Biological & pharmaceutical bulletin. Jan 2025. 48(1):46-50.
- Komaki H, Takeshita E, Kunitake K, Ishizuka T, Shimizu-Motohashi Y, Ishiyama A, Sasaki M, Yonee C, Maruyama S, Hida E, Aoki Y. Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy. Cell Reports Medicine. Jan 2025. 6(1):101901-101901.
学会等発表
- 笹原祐介, 村田泰三, 権泰史, 武田理宏, 飛田英祐. 日常診療記録を用いた臨床試験の登録票データ構築の検討.日本臨床試験学会第16回学術集会総会. 2025年2月28日-3月1日. パシフィコ横浜 会議センター.